MedPath

this is study of the effect of N acetyl cysteine(an old drug already used in different variety of liver failure) on a type of liver failure

Not Applicable
Conditions
Health Condition 1: K729- Hepatic failure, unspecified
Registration Number
CTRI/2020/04/024508
Lead Sponsor
AIIMS BHUBANESWAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients satisfying the definition criteria of acute on chronic liver failure as led by Asian pacific association for the study of liver disease

Exclusion Criteria

1.Patients with hepatocellular carcinoma

2.Patients with serious underlying respiratory illness(s).

3.Patients with underlying serious cardiac illness(s).

4.Patients with underlying serious neurological illness(s).

5.Patients who tested HIV positive during or before enrolment of study.

6.Patients who opted for liver transplantation or not given consent.

7.Pregnant patients.

8.Patients known to have allergic reaction to N acetylcystine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath